Criminal Kvnt...Dr. Jeanne Marrazzo, the newly minted successor to Dr Anthony Fauci at the National Institute for Allergy and Infectious Diseases (NIAID), was recently
one of America’s chief hype women for an antiviral drug that is now unanimously considered an unsafe and catastrophically failed treatment for Covid-19.https://www.dossier.today/p/fauci-successor-at-niaid-peddledGiven the UAB-Gilead
partnership, one would think that
Dr. Marrazzo would refrain from commenting on issues through which she maintained a clear conflict of interest. Or at the very least, she had the duty to disclose her conflict of interest when speaking to the media about the UAB-developed “wonder drug.” She did no such thing.
Even worse,
Dr. Marrazzo bashed harmless and low cost alternatives like hydroxychloroquine, while
hyping the super expensive Gilead-UAB competitor drug.“The hope was maybe, if you treat early in the disease, you don’t need a silver bullet”
such as remdesivir, she told The Washington Post in a July 2020 piece.
“Hospitals are on the razor’s edge,” she added, contributing to the fear and paranoia that was enveloping the nation at the time.
In interview after interview, Dr. Marrazzo had nothing but good things to say about remdesivir, despite the incredible lack of data available to support her outandish claims about the drug.Undoubtedly,
Marrazzo’s Remdesivir maximalism had disastrous implications for patients hospitalized at UAB.
The so-called silver bullet later took on a morbid nickname, “run, death is near,” because of the severe side effect portfolio associated with the IV drug. The headlines speak for themselves:Remdesivir not only failed, but actively harmed hospitalized patients, who were being injected with the antiviral agent following the recommendations of Dr. Marrazzo.
The most exhaustive studies on the Gilead-UAB drug show that there are zero clinical benefits to injecting patients with remdesivir.
Many studies show that Remdesivir can severely injure vital organs such as the heart and kidneys.
